Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2020-04-06 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement (No. 22) detailing the specific transactions made under a stock buyback program. It provides a summary table of daily transactions, total accumulated shares, and a detailed appendix of individual trades, which is characteristic of a 'Transaction in Own Shares' (POS) filing. It is not a report publication announcement (RPA) because it contains the actual transaction data rather than just a notice of a report's availability.
2020-04-06 English
Regulatory Filings 2020
Regulatory Filings Classification · 99% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’s stock buyback program". This indicates the document itself is merely an announcement about the transaction details, not the detailed report of the transactions. The subject matter is the company buying back its own shares. According to the definitions, 'Transaction in Own Shares' (POS) covers reports of the company buying back shares. However, due to the 'MENU VS MEAL' rule (short announcement pointing to a full document), and the nature of this being a brief notification, it fits best as a Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS) if RPA is too specific for a buyback notice. Since the core topic is share repurchase, and it's a brief announcement, RPA is appropriate as it announces the publication of the detailed transaction report. If the full PDF were provided, it would be POS. Given the context of announcing the availability of the detailed report, RPA is the most fitting classification based on the provided text structure.
2020-04-06 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is a formal announcement titled 'Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram' (Transactions related to Novozymes' share buyback program). It details the number of shares bought back, the transaction value, and provides a detailed appendix of daily trades for the period ending April 6, 2020. This content directly relates to the company repurchasing its own shares. This matches the definition for 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a proxy statement (DEF 14A) or an earnings release (ER).
2020-04-06 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (365 characters) and explicitly states that the full announcement regarding 'Transactions under Novozymes’s stock buyback program' is available in an attached PDF. This structure—a brief notice pointing to a separate, detailed document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), according to the 'MENU VS MEAL' rule. Since the content specifically relates to the company transacting in its own shares (stock buyback), the most precise category is Transaction in Own Shares (POS). However, because this document is merely an announcement *of* the transaction details being elsewhere (the attached PDF), it functions as a publication announcement. Given the options, POS is the subject matter, but RPA/RNS is the document *type* based on length and structure. Since the subject matter is clearly 'Transaction in Own Shares', and this is a notification about that transaction, I will prioritize the subject matter if it fits a specific code. POS covers 'Report of the company buying back or selling its own shares'. This is a notification about that activity. If the attached PDF contains the detailed transaction report, this short text is the announcement of that report. I will classify it as RPA because it announces the publication of the details, adhering strictly to the 'MENU VS MEAL' rule for short documents pointing elsewhere. If the subject matter was not covered by RPA/RNS, POS would be the next best fit.
2020-03-31 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (376 characters) and explicitly states that the full message regarding 'Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram' (Transactions related to Novozymes' share buyback program) is in the 'vedhæftede fil' (attached file). This structure—a brief announcement pointing to a separate, detailed document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), based on the 'MENU VS MEAL' rule. Since the content specifically relates to the company buying back its own shares, the most precise category is Transaction in Own Shares (POS). However, because this document is merely an announcement *about* the transaction details being in an attachment, it functions as a publication announcement. Given the specific nature of the content (share buyback), POS is the underlying subject, but RPA/RNS is the document *type* based on length and structure. Since POS is a specific filing type for buybacks, and this is the announcement of that filing/information, I will check if POS covers the announcement itself. POS covers the report of the transaction. Given the strong indication of a share repurchase program, and the short nature suggesting an announcement of the detailed filing, I will classify it as POS, as it is the most specific subject matter, assuming the attached file contains the required POS details. If the attached file were the actual POS, this short text would be the RPA. Given the context of financial filings, this short notice announcing the availability of the buyback details is best classified as POS, as it directly relates to the transaction itself, or RPA if strictly following the 'announcement' rule. Since the subject is 'share buyback program', POS is the most relevant topic code. I will lean towards POS as the subject matter is highly specific, even if the format is an announcement wrapper.
2020-03-31 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Novozymes regarding transactions made under their share buyback program. It details the number of shares purchased, the average price, and the total transaction value over a specific period (March 23-27, 2020). It also includes an appendix with granular trade data. This falls under the category of a company reporting on its own share repurchase activity, which is classified as 'Transaction in Own Shares'.
2020-03-31 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.